Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2643079513;79514;79515 chr2:178566844;178566843;178566842chr2:179431571;179431570;179431569
N2AB2478974590;74591;74592 chr2:178566844;178566843;178566842chr2:179431571;179431570;179431569
N2A2386271809;71810;71811 chr2:178566844;178566843;178566842chr2:179431571;179431570;179431569
N2B1736552318;52319;52320 chr2:178566844;178566843;178566842chr2:179431571;179431570;179431569
Novex-11749052693;52694;52695 chr2:178566844;178566843;178566842chr2:179431571;179431570;179431569
Novex-21755752894;52895;52896 chr2:178566844;178566843;178566842chr2:179431571;179431570;179431569
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Fn3-80
  • Domain position: 45
  • Structural Position: 60
  • Q(SASA): 0.2583
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/A None None 0.45 N 0.505 0.337 0.256283259241 gnomAD-4.0.0 1.20033E-06 None None None None N None 0 0 None 0 0 None 0 0 1.31252E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.3968 ambiguous 0.2906 benign -0.295 Destabilizing 0.45 N 0.505 neutral N 0.474074128 None None N
G/C 0.6716 likely_pathogenic 0.5635 ambiguous -0.889 Destabilizing 1.0 D 0.778 deleterious N 0.513702906 None None N
G/D 0.9468 likely_pathogenic 0.9284 pathogenic -0.504 Destabilizing 0.999 D 0.72 prob.delet. N 0.512030045 None None N
G/E 0.9548 likely_pathogenic 0.93 pathogenic -0.668 Destabilizing 0.998 D 0.724 prob.delet. None None None None N
G/F 0.9705 likely_pathogenic 0.9502 pathogenic -1.005 Destabilizing 1.0 D 0.8 deleterious None None None None N
G/H 0.9395 likely_pathogenic 0.9224 pathogenic -0.504 Destabilizing 1.0 D 0.775 deleterious None None None None N
G/I 0.9065 likely_pathogenic 0.8487 pathogenic -0.45 Destabilizing 0.999 D 0.795 deleterious None None None None N
G/K 0.9816 likely_pathogenic 0.9751 pathogenic -0.799 Destabilizing 0.998 D 0.724 prob.delet. None None None None N
G/L 0.9156 likely_pathogenic 0.8651 pathogenic -0.45 Destabilizing 0.996 D 0.742 deleterious None None None None N
G/M 0.9286 likely_pathogenic 0.8791 pathogenic -0.501 Destabilizing 1.0 D 0.779 deleterious None None None None N
G/N 0.8237 likely_pathogenic 0.7568 pathogenic -0.442 Destabilizing 0.999 D 0.728 prob.delet. None None None None N
G/P 0.9954 likely_pathogenic 0.9932 pathogenic -0.366 Destabilizing 0.999 D 0.767 deleterious None None None None N
G/Q 0.9291 likely_pathogenic 0.8986 pathogenic -0.727 Destabilizing 1.0 D 0.781 deleterious None None None None N
G/R 0.9423 likely_pathogenic 0.925 pathogenic -0.352 Destabilizing 0.999 D 0.782 deleterious N 0.47571997 None None N
G/S 0.229 likely_benign 0.1691 benign -0.598 Destabilizing 0.995 D 0.653 neutral N 0.451730948 None None N
G/T 0.6217 likely_pathogenic 0.5078 ambiguous -0.692 Destabilizing 0.998 D 0.709 prob.delet. None None None None N
G/V 0.7998 likely_pathogenic 0.698 pathogenic -0.366 Destabilizing 0.995 D 0.738 prob.delet. N 0.481520094 None None N
G/W 0.9504 likely_pathogenic 0.9319 pathogenic -1.144 Destabilizing 1.0 D 0.776 deleterious None None None None N
G/Y 0.9567 likely_pathogenic 0.9352 pathogenic -0.806 Destabilizing 1.0 D 0.793 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.